You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lung Cancer Stage II

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

Recruiting
  • Nonsmall Cell Lung Cancer
  • +3 more
  • Genomically Guided Radiation Therapy (RT)
  • Tampa, Florida
    Moffitt Cancer Center
May 23, 2023

Lung Cancer, Nonsmall Cell, Lung Cancer Stage I, Lung Cancer Stage II Trial in Columbia (Breathe Easier Progressive Web

Not yet recruiting
  • Lung Cancer, Nonsmall Cell
  • +3 more
  • Breathe Easier Progressive Web Application
  • Columbia, South Carolina
    University of South Carolina
Sep 22, 2023

Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,

Not yet recruiting
  • Limited Stage Lung Small Cell Carcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Nov 10, 2023

NSCLC, Non-small Cell Carcinoma, NSCLC Stage I Trial (Stereotactic body radiotherapy, Hypofractionated radiotherapy, Durvalumab)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +4 more
  • Stereotactic body radiotherapy
  • +2 more
  • (no location specified)
Jul 5, 2022

Stage I - II Primary Lung Cancer, Stage I Lung Cancer, Stage II Lung Cancer Trial in Boston (AveCure 16 Gauge Flexible Microwave

Not yet recruiting
  • Stage I - II Primary Lung Cancer
  • +5 more
  • AveCure 16 Gauge Flexible Microwave Ablation Probe
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Mar 11, 2022

NSCLC Trial in Shanghai (SH-1028 tablets, Placebo SH-1028 tablets)

Recruiting
  • Non-small Cell Lung Cancer
  • SH-1028 tablets
  • Placebo SH-1028 tablets
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Oct 6, 2023

Extensive Stage Small Cell Lung Cancer Trial (hSTC810 400 mg + Paclitaxel, hSTC810 800 mg + Paclitaxel)

Not yet recruiting
  • Extensive Stage Small Cell Lung Cancer
  • hSTC810 400 mg + Paclitaxel
  • hSTC810 800 mg + Paclitaxel
  • (no location specified)
Aug 24, 2023

Resectable Stage II-IIIB Driver Gene-negative Non-small Cell

Not yet recruiting
  • NSCLC
    • Changsha, Hunan, China
      Hunan Cancer Hospital
    Aug 6, 2023

    Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)

    Not yet recruiting
    • Lung Cancer, Nonsmall Cell
    • Lung Cancer Stage III
    • Nivolumab and Chemotherapy
    • +3 more
    • (no location specified)
    Aug 15, 2023

    Extensive-stage Small Cell Lung Cancer Trial in Tianjin (Selinexor,Olaparib)

    Recruiting
    • Extensive-stage Small Cell Lung Cancer
    • Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Jul 27, 2023

    Lung Cancer, Lung Cancer Stage I, Lung Cancer Stage II Trial in Mission Viejo, New York (CivaSheet)

    Recruiting
    • Lung Cancer
    • +2 more
    • CivaSheet
    • Mission Viejo, California
    • +2 more
    May 23, 2022

    Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated

    Enrolling by invitation
    • Cardiotoxicity
    • +3 more
    • Chemoradiation
    • Birmingham, Alabama
    • +6 more
    Nov 1, 2022

    NSCLC, NSCLC, Lung Cancer Trial in United States (Durvalumab, Stereotactic Body Radiation Therapy)

    Recruiting
    • NSCLC
    • +7 more
    • Hartford, Connecticut
    • +8 more
    Jul 7, 2022

    Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

    Recruiting
    • Anatomic Stage I Breast Cancer AJCC v8
    • +6 more
    • Biopsy
    • +3 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Jan 6, 2023

    Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8 Trial in Los Angeles (Atezolizumab

    Recruiting
    • Lung Non-Small Cell Carcinoma
    • +10 more
    • Atezolizumab and Recombinant Human Hyaluronidase
    • Survey Administration
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Jan 31, 2023

    NSCLC Stage IB, NSCLC Stage II, NSCLC Stage ?A Trial in Kashiwa, Shinjuku-Ku (Pembrolizumab, Ramucirumab, Surgery)

    Recruiting
    • Non-small Cell Lung Cancer Stage IB
    • +2 more
    • Kashiwa, Chiba, Japan
    • +1 more
    Apr 4, 2022

    NSCLC Trial in Shanghai (SBRT+LDRT, Toripalimab, Chemotherapy drug)

    Recruiting
    • NSCLC
    • SBRT+LDRT
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Chest Hospital
    Apr 2, 2023

    NSCLC, NSCLC Stage I, NSCLC Stage II Trial in Stanford (AVENIO ctDNA Surveillance Kit, Durvalumab)

    Recruiting
    • Non-small Cell Lung Cancer
    • +3 more
    • Stanford, California
      Stanford University
    Mar 25, 2022

    Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer Trial in Nashville (drug, biological, radiation, procedure)

    Not yet recruiting
    • Extensive Stage Lung Small Cell Carcinoma
    • Stage IV Lung Cancer
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Oct 25, 2023

    Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8 Trial in Rochester (Best Practice,

    Not yet recruiting
    • Lung Non-Small Cell Carcinoma
    • +3 more
    • Best Practice
    • +4 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Nov 14, 2023

    Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Buffalo (Best Practice,

    Not yet recruiting
    • Lung Non-Small Cell Carcinoma
    • +8 more
    • Best Practice
    • +2 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Dec 29, 2022

    Small Cell Lung Cancer Extensive Stage Trial in Jinan, Tianjin, Zhengzhou (IN10018, Tislelizumab, Carboplatin)

    Not yet recruiting
    • Small Cell Lung Cancer Extensive Stage
    • Jinan, China
    • +2 more
    Sep 10, 2023

    Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Trial in

    Recruiting
    • Locally Advanced Lung Non-Small Cell Carcinoma
    • +12 more
    • Computed Tomography
    • Contrast Agent
    • New Brunswick, New Jersey
    • +1 more
    Nov 2, 2022

    Metastatic NSCLC (NSCLC), NSCLC Metastatic, NSCLC Stage II Trial in Oldenburg (data collection)

    Recruiting
    • Metastatic Non-small Cell Lung Cancer (NSCLC)
    • +5 more
    • data collection
    • Oldenburg, Germany
      Pius-Hospital
    Jul 20, 2022

    Small Cell Lung Cancer, SCLC, Extensive Stage Small Cell Lung Cancer Trial (Durvalumab, Monalizumab, Carboplatin or Cisplatin)

    Not yet recruiting
    • Small Cell Lung Cancer
    • +2 more
    • (no location specified)
    Jun 5, 2023